Gamma-glutamyltransferase (GGT) - A novel marker of endothelial dysfunction?

Journal, Indian Academy of Clinical Medicine

Volumn 11, Issue 1, 2010, Pages 26-30

  Sharma, R ^a   Sharma, S ^a   Kaushik, G G ^a  

^a J L N MEDICAL COLLEGE   (India)

Author keywords

C reactive protein; Gamma glutamyltranferase; Inflammation; Oxidative stress; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE;

EID: 77954265388     PISSN: 09723560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31 (Suppl. 1): S55-S60.
2. Ceriello A. Post-prandial hyperglycaemia and diabetes complications: is it time to treat? Diabetes 2005; 54 (1): 1-7.
3. Warram JH, Martin BC, Krolewski AS et al. Slow glucose removal rate and hyperinsulinaemia precede the development of type-II diabetes in the offspring of diabetic parents. Ann Intern Med 1990; 113: 909-15.
4. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen and leucocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003; 168: 351-8.
5. Pradhan AD, Manson JE, Rifai N et al. C-reactive protein, interleukin-6 and risk of developing type 2 diabetes mellitus. J Am Med Assoc 2001; 286: 327-34.
6. Thorand B, Lowel H, Schneider A et al. C-reactive protein as a predictor for incident diabetes mellitus among middle- aged men: Results from the MONICA Augsburg Cohort Study, 1984-1998. Arch Intern Med 2003; 163: 93-9.
7. Laaksonen DE, Niskanen L, Nyyssonen K et al. C-reactive protein and the development of metabolic syndrome and diabetes in middle-aged men. Diabetologia 2004; 47: 1403-10.
8. Lee DH, Jacobs DR Jr, Gross M et al. Gamma- glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49: 1358-66.
9. Nakanishi N, Nishina K, Li W et al. Serum gamma- glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 2003; 254: 287-95.
10. Nakanishi N, Suzuki K, Tatara K. Serum gamma- glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004; 27: 1427-32.
11. Pleiner J, Mittermayer F, Schaller G et al. Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress. J Am Coll Cardiol 2003; 42: 1656-62.
12. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6: 24.
13. Otsuji S, Shibata H, Umeda M. Turbidimetric immunoassay of serum C-reactive protein. Clinical Chemistry 1982; 28 (10): 2121-4.
14. Trivelli LA, Ranney HM, Lai HT. Haemoglobin components in patients with diabetes mellitus. N Engl J Med 1971; 284: 353-7.
15. Szasz G. A Kinetic Photometric Method for Serum Gamma Glutamyl Transferase. Clin Chem 1969; 15 (2): 124-36.
16. Lee DH, Ha MH, Kim JH et al. Gamma-glutamyltransferase and diabetes- a 4 year follow-up study. Diabetologia 2003; 46: 359-64.
17. Lim JS, Yang JH, Chun BY et al. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med 2004; 37: 1018-23.
18. Drozdz R, Parmentier C, Hachad H et al. Gamma-glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 1998; 25: 786-92.
19. Nystrom E, Bengtsson C, Lindstedt G et al. Serum gamma-glutamyltransferase in a Swedish female population. Age- related reference intervals; morbidity and prognosis in cases with raised catalytic concentration. Acta Med Scand 1988; 224: 79-84.
20. Nilssen O, Forde OH, Brenn T. The Tromso Study. Distribution and population determinants of gamma- glutamyltransferase. Am J Epidemiol 1990; 132: 318-26.
21. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischaemic heart disease and all causes. Am J Epidemiol 1995; 142: 699-708.
22. Brenner H, Rothenbacher D, Arndt V et al. Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany. Prev Med 1997; 26: 305-107.